Seroprevalence of Parvovirus B19 in the German Population

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2008 Jan 17

PMID 18198003

Citations 43

Authors

C Rohrer

B Gartner

A Sauerbrei

S Bohm

B Hottentrager

U Raab

W Thierfelder

P Wutzler

S Modrow

Affiliations

Soon will be listed here.

Abstract

Acute parvovirus B19 infection is a risk for pregnant women. After vertical transmission the infected fetus may develop hydrops fetalis. Since B19 infection occurs mainly during childhood, children represent a main source for virus transmission. In order to determine whether certain groups in the German population show increased risks for B19 infection we analysed the seroprevalence using 6583 sera collected from adults in former Eastern and Western Germany during the German National Health Survey and 649 sera from healthy Thuringian children and adolescents. In adults the overall seroprevalence was 72.1%, rising from 20.4% in children (1-3 years) and 66.9% in adolescents (18-19 years) to 79.1% in the elderly (65-69 years). Significant differences were observed between females (73.3%) and males (70.9%) and between inhabitants of small (74.8%) and big cities (69.0%) but not between people of the former Eastern (72.8%) and Western states (72.0%) of Germany. For women during childbearing age (18-49 years) highest values were observed in those living together with two or more children (81.6%) and in women with occupational contact with children aged <6 years (88.9%). In contrast seroprevalence was significantly lower in age-matched female singles (64.8%) and in women with occupational contact with children aged >6 years and adolescents (63.8%).

Citing Articles

Parvovirus B19-related membranoproliferative glomerulonephritis presenting with positive glomerular staining for nephritis-associated plasmin receptor: a case report and review of the literature.

Takahashi H, Wada Y, Yamazaki T, Takeuchi K, Abe T, Naito S CEN Case Rep. 2024; .

PMID: 39674998 DOI: 10.1007/s13730-024-00956-1.

Increased parvovirus B19 seropositivity in healthy blood donors in India.

Kumari S, Kuruvilla Thomas R, Sruthi S, Barani R, Sangvi S, Krishnamoorthy R Sci Rep. 2024; 14(1):20497.

PMID: 39227628 PMC: 11372103. DOI: 10.1038/s41598-024-68095-2.

Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023).

Vukovic V, Patic A, Ristic M, Kovacevic G, Hrnjakovic Cvjetkovic I, Petrovic V Viruses. 2024; 16(2).

PMID: 38399956 PMC: 10893261. DOI: 10.3390/v16020180.

Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens.

Healy K, Aulin L, Freij U, Ellerstad M, Bruckle L, Hillmering H J Infect Dis. 2022; 227(10):1214-1218.

PMID: 36408632 PMC: 10175064. DOI: 10.1093/infdis/jiac456.

The role of virus infections in Sjögren's syndrome.

Maslinska M, Kostyra-Grabczak K Front Immunol. 2022; 13:823659.

PMID: 36148238 PMC: 9488556. DOI: 10.3389/fimmu.2022.823659.

References

Miller E, Fairley C, Cohen B, Seng C . Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998; 105(2):174-8. DOI: 10.1111/j.1471-0528.1998.tb10048.x. View

Letaief M, Vanham G, Boukef K, Yacoub S, Muylle L, Mertens G . Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci. 1997; 18(4):523-30. DOI: 10.1016/s0955-3886(97)00049-0. View

Gilbert G . Parvovirus B19 infection and its significance in pregnancy. Commun Dis Intell. 2000; 24 Suppl:69-71. View

Kelly H, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W . The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000; 124(3):449-57. PMC: 2810931. DOI: 10.1017/s0950268899003817. View

Odland J, Sergejeva I, Ivaneev M, Jensen I, Stray-Pedersen B . Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta Obstet Gynecol Scand. 2001; 80(11):1025-9. DOI: 10.1034/j.1600-0412.2001.801110.x. View

Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R . Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol. 2002; 17(5):429-35. DOI: 10.1023/a:1013792013184. View

Heegaard E, Brown K . Human parvovirus B19. Clin Microbiol Rev. 2002; 15(3):485-505. PMC: 118081. DOI: 10.1128/CMR.15.3.485-505.2002. View

Enders M, Weidner A, Zoellner I, Searle K, Enders G . Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004; 24(7):513-8. DOI: 10.1002/pd.940. View

Yaegashi N, Niinuma T, Chisaka H, Watanabe T, Uehara S, Okamura K . The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect. 1998; 37(1):28-35. DOI: 10.1016/s0163-4453(98)90346-2. View

10.

Rodis J, Borgida A, Wilson M, Egan J, Leo M, Odibo A . Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol. 1998; 179(4):985-8. DOI: 10.1016/s0002-9378(98)70203-0. View

11.

Yaegashi N, Niinuma T, Chisaka H, Uehara S, Okamura K, Shinkawa O . Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect. 1999; 38(1):30-5. DOI: 10.1016/s0163-4453(99)90026-9. View

12.

Pedersen C, Westergaard T, Jensen I, Lebech M, Andersen P, Aaby P . Risk factors for parvovirus B19 infection in pregnancy. JAMA. 1999; 281(12):1099-105. DOI: 10.1001/jama.281.12.1099. View

13.

Ferguson M, Heath A . Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody. Biologicals. 2004; 32(4):207-12. DOI: 10.1016/j.biologicals.2004.09.004. View

14.

Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpaa R . Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 2005; 112(1):50-6. DOI: 10.1111/j.1471-0528.2004.00320.x. View

15.

Hellenbrand W, Thierfelder W, Muller-Pebody B, Hamouda O, Breuer T . Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998. Eur J Clin Microbiol Infect Dis. 2005; 24(2):131-5. DOI: 10.1007/s10096-005-1286-x. View

16.

Gilbert N, Gyorkos T, Beliveau C, Rahme E, Muecke C, Soto J . Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect. 2005; 133(2):299-304. PMC: 2870249. DOI: 10.1017/s0950268804003474. View

17.

Pfrepper K, Enders M, Motz M . Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J Vet Med B Infect Dis Vet Public Health. 2005; 52(7-8):362-5. DOI: 10.1111/j.1439-0450.2005.00874.x. View

18.

Chisaka H, Ito K, Niikura H, Sugawara J, Takano T, Murakami T . Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med. 2006; 209(4):277-83. DOI: 10.1620/tjem.209.277. View

19.

van Gessel P, Gaytant M, Vossen A, Galama J, Ursem N, Steegers E . Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study. Eur J Obstet Gynecol Reprod Biol. 2006; 128(1-2):46-9. DOI: 10.1016/j.ejogrb.2005.11.042. View

20.

Enders M, Weidner A, Enders G . Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect. 2006; 135(4):563-9. PMC: 2870617. DOI: 10.1017/S095026880600731X. View